http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2573844-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D321-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D321-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-58 |
| filingDate | 2005-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_117631430950a2360d8479befbc6f35d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a26c80a6a5158a981fa3b245367120a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57715e2f20aa959444e741d1e48aed05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d7e706a6cf7452432c2c6ab9a65e8ec |
| publicationDate | 2016-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2573844-T3 |
| titleOfInvention | Sulfamide and sulfamate derivatives for the treatment of epilepsy and related disorders |
| abstract | A compound of formula (II) ** Formula ** in which R1 and R2 are independently selected from the group consisting of hydrogen and lower alkyl; R4 is selected from the group consisting of hydrogen and lower alkyl; a is an integer from 1 to 2; ** Formula ** is selected from the group consisting of 2- (2,3-dihydro-benzo [1,4] dioxinyl), 2- (benzo [1,3] dioxolyl ), 3- (3,4-dihydro-2H-benzo [1,4] dioxepinyl), 2- (6-chloro-2,3-dihydro-benzo [1,4] dioxinyl), 2- (6-fluoro -2,3-dihydrobenzo [1,4] dioxinyl), 2- (chromanyl), 2- (5-fluoro-2,3-dihydro-benzo [1,4] dioxinyl), 2- (7-chloro-2 , 3-dihydro benzo [1,4] dioxinyl), 2 2- (7-methyl-2,3-dihydro-benzo [1,4] dioxinyl), 2- (5-chloro-2,3-dihydro-benzo [1,4] dioxinyl), 2- (6-bromo-2,3-dihydro-benzo [1,4] dioxinyl), 2- (6,7-dichloro-2,3-dihydro-benzo [1,4 ] dioxinyl), 2- (8-chloro-2,3-dihydrobenzo [1,4] dioxinyl) and 2- (2,3-dihydro-naphtho [2,3-b] [1,4] dioxinyl); provided that when ** Formula ** is 3- (3,4-dihydro-2H-benzo [1,4] dioxepinyl), then a is 1; where "lower" when used with alkyl means a carbon chain composition of 1-4 carbon atoms; or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2004-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 160.